Irish Startups Secure Early 2026 Funding

Venture capital poured over $252 million into Irish startups across six equity funding rounds in the first two months of 2026. This figure, however, represents a 38.32% decrease compared to the $408 million raised in 16 rounds during the same period in 2025. Quantum computing startup Equal1 led the charge with a significant $60 million funding round to support the deployment of Ireland's first homegrown quantum processing unit. The round was led by the Ireland Strategic Investment Fund, with participation from Atlantic Bridge and the European Innovation Council Fund, among others. The medtech sector also saw substantial investment, with Galway-based Neurent Medical closing a €62.5 million Series C financing round. This funding, led by MVM Partners, is earmarked for its Neuromark medical device, which treats chronic rhinitis. Another notable raise came from RNA biotech company Aerska, which secured a $39 million Series A round to develop medicines for brain diseases. Other significant early-year funding recipients included Dublin-based fintech Circit, which raised $22 million in growth equity, and edtech platform AICertified, which secured €1 million. The health-tech startup Linda AI, with operations in Dublin and London, also announced a €2.6 million pre-seed round. Despite these successes, many Irish founders still find attracting private capital to be a major challenge. A 2025 government report highlighted a potential €1.1 billion gap in equity financing for scale-up enterprises over the next three to five years. To bolster the ecosystem, the Irish government offers various supports. Budget 2026 increased the Research & Development tax credit from 30% to 35%. Additionally, state agency Enterprise Ireland plays a crucial role, offering a range of grants and participating in funding rounds for many startups.